{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:40:49Z","timestamp":1792518049729,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jhep.2024.08.008","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T23:47:43Z","timestamp":1724370463000},"page":"189-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Thyroid hormone receptor-beta agonist HSK31679 alleviates MASLD by modulating gut microbial sphingolipids"],"prefix":"10.1016","volume":"82","author":[{"given":"Yu-Hang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Shu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6520-0809","authenticated-orcid":false,"given":"Hong-Wei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Tian","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2605-5697","authenticated-orcid":false,"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Min","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2024.08.008_bib1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41587-024-02220-4","volume":"42","year":"2024","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jhep.2024.08.008_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/d41573-024-00051-1","article-title":"Nash field celebrates 'hurrah moment' with a first FDA drug approval for the liver disease","volume":"23","author":"Kingwell","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jhep.2024.08.008_bib3","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(19)32517-6","article-title":"Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"394","author":"Harrison","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2024.08.008_bib4","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1021\/acs.jmedchem.2c01669","article-title":"Discovery of highly potent and selective thyroid hormone receptor beta agonists for the treatment of nonalcoholic steatohepatitis","volume":"66","author":"Hu","year":"2023","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jhep.2024.08.008_bib5","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1111\/bph.15427","article-title":"Activation of thyroid hormone receptor-beta improved disease activity and metabolism independent of body weight in a mouse model of non-alcoholic steatohepatitis and fibrosis","volume":"178","author":"Kannt","year":"2021","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jhep.2024.08.008_bib6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A\u00a0phase 3, randomized, controlled trial of Resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2024.08.008_bib7","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1021\/jm4019299","volume":"57","author":"Kelly","year":"2014","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jhep.2024.08.008_bib8","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1038\/s41467-022-33050-0","article-title":"An online atlas of human plasma metabolite signatures of gut microbiome composition","volume":"13","author":"Dekkers","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2024.08.008_bib9","first-page":"2020","article-title":"NCBI Taxonomy: a comprehensive update on curation, resources and tools","author":"Schoch","year":"2020","journal-title":"Database (Oxford)"},{"key":"10.1016\/j.jhep.2024.08.008_bib10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","article-title":"A\u00a0simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer","volume":"69","author":"Tsuchida","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.08.008_bib11","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1038\/s41467-020-16274-w","article-title":"Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels","volume":"11","author":"Johnson","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2024.08.008_bib12","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","article-title":"Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species","volume":"50","author":"Zilionis","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2024.08.008_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","article-title":"Scanpy: large-scale single-cell gene expression data analysis","volume":"19","author":"Wolf","year":"2018","journal-title":"Genome Biol"},{"key":"10.1016\/j.jhep.2024.08.008_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-physiol-031620-093815","article-title":"Ceramides in metabolism: key lipotoxic players","volume":"83","author":"Chaurasia","year":"2021","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jhep.2024.08.008_bib15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2012.04.005","article-title":"Role of ceramides in nonalcoholic fatty liver disease","volume":"23","author":"Pagadala","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jhep.2024.08.008_bib16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41574-020-0320-5","article-title":"The role of ceramides in metabolic disorders: when size and localization matters","volume":"16","author":"Turpin-Nolan","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jhep.2024.08.008_bib17","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.chom.2022.05.002","article-title":"Host hepatic metabolism is modulated by gut microbiota-derived sphingolipids","volume":"30","author":"Le","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jhep.2024.08.008_bib18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/ni.2227","article-title":"The composition and signaling of the IL-35 receptor are unconventional","volume":"13","author":"Collison","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2024.08.008_bib19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4049\/immunohorizons.2300039","article-title":"Human IL-35 inhibits the bioactivity of IL-12 and its interaction with IL-12Rbeta2","volume":"7","author":"Mahfooz","year":"2023","journal-title":"Immunohorizons"},{"key":"10.1016\/j.jhep.2024.08.008_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8494076","article-title":"Gamma-glutamyltransferase activity (GGT) is a long-sought biomarker of redox status in blood circulation: a retrospective clinical study of 44 types of human diseases","volume":"2022","author":"Bai","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jhep.2024.08.008_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","article-title":"Noninvasive biomarkers in NAFLD and NASH - current progress and future promise","volume":"15","author":"Wong","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.08.008_bib22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41591-021-01668-0","article-title":"Publisher correction: XCR1(+) type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis","volume":"28","author":"Deczkowska","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2024.08.008_bib23","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jhep.2017.01.008","article-title":"Murine CD103(+) dendritic cells protect against steatosis progression towards steatohepatitis","volume":"66","author":"Heier","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.08.008_bib24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s42003-024-05813-6","article-title":"Effects of iodine intake on gut microbiota and gut metabolites in Hashimoto thyroiditis-diseased humans and mice","volume":"7","author":"Gong","year":"2024","journal-title":"Commun Biol"},{"key":"10.1016\/j.jhep.2024.08.008_bib25","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cmet.2021.06.006","article-title":"Sphingolipids in metabolic disease: the good, the bad, and the unknown","volume":"33","author":"Green","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2024.08.008_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jhep.2024.08.008_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jhep.2024.08.008_bib28","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/nutrit\/nux004","article-title":"Dietary sphingolipids: potential for management of dyslipidemia and nonalcoholic fatty liver disease","volume":"75","author":"Norris","year":"2017","journal-title":"Nutr Rev"},{"key":"10.1016\/j.jhep.2024.08.008_bib29","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.chom.2019.04.002","article-title":"Bacteroides-derived sphingolipids are critical for maintaining intestinal homeostasis and symbiosis","volume":"25","author":"Brown","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jhep.2024.08.008_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cell.2013.11.042","article-title":"Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells","volume":"156","author":"An","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2024.08.008_bib31","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1089\/thy.2010.0429","article-title":"Thyroid hormones as modulators of immune activities at the cellular level","volume":"21","author":"De Vito","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.jhep.2024.08.008_bib32","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1530\/EJE-21-1171","article-title":"The interplay of thyroid hormones and the immune system - where we stand and why we need to know about it","volume":"186","author":"Wenzek","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jhep.2024.08.008_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade3157","article-title":"Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis","volume":"15","author":"Mooring","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2024.08.008_bib34","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1172\/JCI134214","article-title":"Osteocyte necrosis triggers osteoclast-mediated bone loss through macrophage-inducible C-type lectin","volume":"130","author":"Andreev","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2024.08.008_bib35","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2120489119","article-title":"A\u00a0mechanism of self-lipid endocytosis mediated by the receptor mincle","volume":"119","author":"Kostarnoy","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.jhep.2024.08.008_bib36","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/CIRCULATIONAHA.118.035235","article-title":"Loss of gut microbiota alters immune system composition and cripples postinfarction cardiac repair","volume":"139","author":"Tang","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2024.08.008_bib37","article-title":"A germ-free humanized mouse model shows the contribution of resident microbiota to human-specific pathogen infection","author":"Wahl","year":"2023","journal-title":"Nat Biotechnol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827824024863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827824024863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T17:50:06Z","timestamp":1736963406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827824024863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0168827824024863"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2024.08.008","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyroid hormone receptor-beta agonist HSK31679 alleviates MASLD by modulating gut microbial sphingolipids","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2024.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}